US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Apogee Therapeutics

40.98

+3.338.84%

Post-market: 40.980.00000.00%16:28 EDT

Volume:1.11M

Turnover:45.62M

Market Cap:2.39B

PE:-11.41

High:42.50

Open:38.45

Low:38.39

Close:37.65

Loading ...

Overview Company News Filings

Apogee Therapeutics' Chief Medical Officer Carl Dambkowski Reports Disposal of Common Shares

Apogee Therapeutics Reports Q1 2025 Progress and Financials

Why Is Apogee Therapeutics Stock Trading Higher On Monday?

Apogee Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Apogee Therapeutics: Promising Biologics Developments Justify Buy Rating

Apogee Therapeutics Q1 EPS $(0.95) Beats $(1.25) Estimate

Apogee Therapeutics Reports Positive Phase 1b Trial Results

Apogee Therapeutics Q1 Loss Widens

MT Newswires Live

Earnings Flash (APGE) Apogee Therapeutics Posts Q1 Net Loss $55.3M, vs. FactSet Est of $72.3M Loss

MT Newswires Live

Apogee Therapeutics Cash, Cash Equivalents And Marketable Securities Were $681.4M As Of March 31, 2025 That Supports Runway Into Q1 2028

Press Release: Apogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial Results

Apogee Therapeutics Inc. Chief Medical Officer Carl Dambkowski Reports Disposal of Common Shares

Apogee Therapeutics to Participate at the Bank of America 2025 Health Care Conference

Companies Like Apogee Therapeutics (NASDAQ:APGE) Are In A Position To Invest In Growth

Simply Wall St.

Apogee Therapeutics price target lowered to $78 from $80 at BofA

Apogee Therapeutics Inc : Jefferies Raises Target Price to $88 From $86

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Metropolitan Bank, Fossil, MeiraGTx

BUZZ-Citi initiates Apogee with "buy" rating on potential for eczema drug

Citigroup Initiates Apogee Therapeutics at Buy With $95 Price Target

MT Newswires Live

BUZZ-Citi starts coverage on 'insulated' SMid biotechs amid healthcare policy uncertainty

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/APGE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APGE\",,,,,undefined,":{"symbol":"APGE","market":"US","secType":"STK","nameCN":"Apogee Therapeutics","latestPrice":40.98,"timestamp":1749240000000,"preClose":37.65,"halted":0,"volume":1112592,"hourTrading":{"tag":"盘后","latestPrice":40.98,"preClose":40.98,"latestTime":"16:28 EDT","volume":42824,"amount":1754927.52,"timestamp":1749241706952},"delay":0,"floatShares":37589079,"shares":58368834,"eps":-3.591044,"marketStatus":"Market Closed","change":3.33,"latestTime":"06-06 16:00:00 EDT","open":38.45,"high":42.4999,"low":38.39,"amount":45618259.055816,"amplitude":0.109161,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.591044,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":37.65,"preHourTrading":{"tag":"盘前","latestPrice":37.97,"preClose":37.65,"latestTime":"08:40 EDT","volume":4,"amount":151.88,"timestamp":1749213617264},"postHourTrading":{"tag":"盘后","latestPrice":40.98,"preClose":40.98,"latestTime":"16:28 EDT","volume":42824,"amount":1754927.52,"timestamp":1749241706952},"volumeRatio":1.2972026113972672,"impliedVol":1.8149,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APGE\",,,,,undefined,":{"symbol":"APGE","floatShares":37589079,"roa":"-19.65%","roe":"-27.85%","lyrEps":-3.300106,"volumeRatio":1.2972026113972672,"shares":58368834,"dividePrice":0,"high":42.4999,"amplitude":0.109161,"preClose":37.65,"low":38.39,"week52Low":26.2,"pbRate":"3.55","week52High":63.5,"institutionHeld":0,"latestPrice":40.98,"eps":-3.591044,"divideRate":0,"volume":1112592,"delay":0,"ttmEps":-3.591044,"open":38.45,"prevYearClose":45.3,"prevWeekClose":36.64,"prevMonthClose":36.64,"prevQuarterClose":37.36,"fiveDayClose":36.64,"twentyDayClose":37.81,"sixtyDayClose":38.53},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APGE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541918018","title":"Apogee Therapeutics' Chief Medical Officer Carl Dambkowski Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2541918018","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541918018?lang=en_us&edition=fundamental","pubTime":"2025-06-07 08:01","pubTimestamp":1749254507,"startTime":"0","endTime":"0","summary":"Carl Dambkowski, Chief Medical Officer of Apogee Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 06, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250607:nNDL9fXQQs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Apogee Therapeutics' Chief Medical Officer Carl Dambkowski Reports Disposal of Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE"],"gpt_icon":0},{"id":"2535692387","title":"Apogee Therapeutics Reports Q1 2025 Progress and Financials","url":"https://stock-news.laohu8.com/highlight/detail?id=2535692387","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535692387?lang=en_us&edition=fundamental","pubTime":"2025-05-13 12:18","pubTimestamp":1747109930,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics, Inc. ( ($APGE) ) has released its Q1 earnings. Here is a breakdown of the information Apogee Therapeutics, Inc. presented to i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apogee-therapeutics-reports-q1-2025-progress-and-financials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apogee-therapeutics-reports-q1-2025-progress-and-financials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065732104.USD","BK4139","PRGS","APGE","BK4097"],"gpt_icon":0},{"id":"2535078819","title":"Why Is Apogee Therapeutics Stock Trading Higher On Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2535078819","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535078819?lang=en_us&edition=fundamental","pubTime":"2025-05-13 02:21","pubTimestamp":1747074086,"startTime":"0","endTime":"0","summary":"Apogee&#39;s APG808 cut key asthma biomarker FeNO by 53% at 12 weeks with no severe adverse events, showing potential for long-term maintenance dosing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/25/05/45357154/why-is-apogee-therapeutics-stock-trading-higher-on-monday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE"],"gpt_icon":0},{"id":"2535207907","title":"Apogee Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535207907","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535207907?lang=en_us&edition=fundamental","pubTime":"2025-05-13 01:23","pubTimestamp":1747070634,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryApogee Therapeutics Inc APGE.OQ reported a quarterly adjusted loss of 95 cents per share for the quarter ended ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nL8N3RK29V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE"],"gpt_icon":0},{"id":"2535008552","title":"Apogee Therapeutics: Promising Biologics Developments Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2535008552","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535008552?lang=en_us&edition=fundamental","pubTime":"2025-05-13 01:15","pubTimestamp":1747070109,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren has maintained their bullish stance on APGE stock, giving a Buy rating on May 7. Tyler Van Buren has given his Buy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/apogee-therapeutics-promising-biologics-developments-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/apogee-therapeutics-promising-biologics-developments-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE"],"gpt_icon":0},{"id":"2534226106","title":"Apogee Therapeutics Q1 EPS $(0.95) Beats $(1.25) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2534226106","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534226106?lang=en_us&edition=fundamental","pubTime":"2025-05-12 19:21","pubTimestamp":1747048869,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics (NASDAQ:APGE) reported quarterly losses of $(0.95) per share which beat the analyst consensus estimate of $(1.25) by 24 percent. This is a 48.44 percent decrease over losses of $(0.64) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45344098/apogee-therapeutics-q1-eps-0-95-beats-1-25-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE"],"gpt_icon":0},{"id":"2534225934","title":"Apogee Therapeutics Reports Positive Phase 1b Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2534225934","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534225934?lang=en_us&edition=fundamental","pubTime":"2025-05-12 18:49","pubTimestamp":1747046967,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics ( ($APGE) ) has issued an announcement. On May 12, 2025, Apogee Therapeutics announced positive interim results from their Phas...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apogee-therapeutics-reports-positive-phase-1b-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apogee-therapeutics-reports-positive-phase-1b-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE","BK4139"],"gpt_icon":0},{"id":"2534553228","title":"Apogee Therapeutics Q1 Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2534553228","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534553228?lang=en_us&edition=fundamental","pubTime":"2025-05-12 18:44","pubTimestamp":1747046657,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics  reported a Q1 net loss Monday of $55.3 million, widening from a loss of $32.1 million a year earlier.Analysts polled by FactSet expected a loss of $72.3 million.The company reported no revenue for the quarter ended March 31, as expected by analysts.Apogee reported cash, cash equivalents and marketable securities of $681.4 million as of March 31. These should be enough to allow the company to fund its operating expenses into Q1 2028, it said.Apogee shares were up 5.6% in recent premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APGE","BK4139"],"gpt_icon":0},{"id":"2534363242","title":"Earnings Flash (APGE) Apogee Therapeutics Posts Q1 Net Loss $55.3M, vs. FactSet Est of $72.3M Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2534363242","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534363242?lang=en_us&edition=fundamental","pubTime":"2025-05-12 18:23","pubTimestamp":1747045390,"startTime":"0","endTime":"0","summary":"Earnings Flash (APGE) Apogee Therapeutics Posts Q1 Net Loss $55.3M, vs. FactSet Est of $72.3M Loss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APGE"],"gpt_icon":0},{"id":"2534869241","title":"Apogee Therapeutics Cash, Cash Equivalents And Marketable Securities Were $681.4M As Of March 31, 2025 That Supports Runway Into Q1 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2534869241","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534869241?lang=en_us&edition=fundamental","pubTime":"2025-05-12 18:09","pubTimestamp":1747044541,"startTime":"0","endTime":"0","summary":"Phase 2 APEX trial of APG777 in atopic dermatitis advancing with interim Part A 16-week data expected in mid-2025 and Part B actively enrollingFirst patient dosed in Phase 1b trial of APG777 in mild-to-moderate asthma","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/25/05/45342762/apogee-therapeutics-cash-cash-equivalents-and-marketable-securities-were-681-4m-as-of-march-31-20","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE"],"gpt_icon":0},{"id":"2534241948","title":"Press Release: Apogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2534241948","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534241948?lang=en_us&edition=fundamental","pubTime":"2025-05-12 18:05","pubTimestamp":1747044300,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial Results. Phase 2 APEX trial of APG777 in atopic dermatitis advancing with interim Part A 16-week data expected in mid-2025 and Part B actively enrolling. First patient dosed in Phase 1b trial of APG777 in mild-to-moderate asthma with readout expected in 1H 2026. APG279 on track to initiate Phase 1b head-to-head trial vs DUPIXENT in 2025 with readout expected in 2H 2026. Positive interim Phase 1b readout of APG808 in patients with mild-to-moderate asthma demonstrated rapid, robust and sustained suppression of FeNO, a biomarker of Type 2 inflammation that is associated with exacerbations in asthma. $681.4 million cash, cash equivalents and marketable securities supports runway into Q1 2028. Apogee conducted third-party quantitative market research in April","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","BK4139","PK","LU2065732104.USD","BK4097","PRGS","TSLP","APGE","BK4218"],"gpt_icon":0},{"id":"2534194498","title":"Apogee Therapeutics Inc. Chief Medical Officer Carl Dambkowski Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2534194498","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534194498?lang=en_us&edition=fundamental","pubTime":"2025-05-10 08:01","pubTimestamp":1746835306,"startTime":"0","endTime":"0","summary":"Carl Dambkowski, the Chief Medical Officer of Apogee Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 09, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250510:nNDL6QVGzv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE"],"gpt_icon":0},{"id":"2532997079","title":"Apogee Therapeutics to Participate at the Bank of America 2025 Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2532997079","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532997079?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:00","pubTimestamp":1746100800,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO and BOSTON, May 01, 2025  -- Apogee Therapeutics, Inc., , today announced that members of management will present at the Bank of America Health Care Conference on Tuesday, May 13, 2025, at 1:40 p.m. P.T. / 4:40 p.m. E.T.A live and archived webcast of the presentation will be available via the News & Events page in the Investors section of the Apogee Therapeutics website.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/apogee-therapeutics-participate-bank-america-120000905.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B1BXHZ80.USD","LU0971096721.USD","LU1668664300.SGD","IE00B19Z3B42.SGD","LU2129689514.USD","LU0320765646.SGD","LU1496350171.SGD","LU0306807586.USD","LU1267930227.SGD","LU1894683264.USD","LU2129689431.USD","LU0787776722.HKD","LU0128525689.USD","LU0256863811.USD","LU1363072403.SGD","BK4588","BK4504","IE00BLSP4452.SGD","LU0417517546.SGD","LU1074936037.SGD","BK4581","IE0002270589.USD","IE00BFXG1179.USD","LU0868494617.USD","LU0106831901.USD","LU1880398471.USD","LU0306806265.USD","APGE","LU0648000940.SGD","LU0980610538.SGD","BK4207","IE00B19Z3581.USD","IE00BBT3K403.USD","IE00B7SZLL34.SGD","LU0130102774.USD","LU0208291251.USD","LU0314106906.USD","LU1791807156.HKD","LU0170899867.USD","IE00BLSP4239.USD","LU1201861249.SGD","LU0321505439.SGD","LU1162221912.USD","LU1496350502.SGD","BK4553","LU1366192091.USD","BAC","LU1201861165.SGD","LU0070302665.USD","LU0130518102.USD"],"gpt_icon":0},{"id":"2529850256","title":"Companies Like Apogee Therapeutics (NASDAQ:APGE) Are In A Position To Invest In Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2529850256","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529850256?lang=en_us&edition=fundamental","pubTime":"2025-04-23 21:02","pubTimestamp":1745413321,"startTime":"0","endTime":"0","summary":"There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly.So, the natural question for Apogee Therapeutics  shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual  free cash flow, which is the amount of money a company spends each year to fund its growth. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.Since it has a market capitalisation of US$1.9b, Apogee Therapeutics' US$172m in cash burn equates to about 9.0% of its market value. That's a low proportion, so we figure the company w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/companies-apogee-therapeutics-nasdaq-apge-130201771.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["APGE","LU2095319765.USD","MNQmain","IE00BKPKM429.USD",".IXIC","IE00B64PRP62.GBP","USJW.SI","LU2210149790.SGD","BK4585","PSQ","NQmain","IE00B3QW5Z07.USD","QLD","TQQQ","QID","BK4139","USAW.SI","NDAQ","BK4112","TSYW.SI","LU2210150020.SGD","IE00BGHQF748.EUR","SQQQ","NVIW.SI","BK4588"],"gpt_icon":1},{"id":"2525189456","title":"Apogee Therapeutics price target lowered to $78 from $80 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2525189456","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525189456?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:35","pubTimestamp":1744115733,"startTime":"0","endTime":"0","summary":"BofA analyst Tim Anderson lowered the firm’s price target on Apogee Therapeutics (APGE) to $78 from $80 and keeps a Buy rating on the shares after ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apogee-therapeutics-price-target-lowered-to-78-from-80-at-bofa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apogee-therapeutics-price-target-lowered-to-78-from-80-at-bofa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE"],"gpt_icon":0},{"id":"2524557116","title":"Apogee Therapeutics Inc : Jefferies Raises Target Price to $88 From $86","url":"https://stock-news.laohu8.com/highlight/detail?id=2524557116","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524557116?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:45","pubTimestamp":1743511547,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF0V0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APGE","BK4139"],"gpt_icon":0},{"id":"2519856750","title":"BUZZ-U.S. STOCKS ON THE MOVE-Metropolitan Bank, Fossil, MeiraGTx","url":"https://stock-news.laohu8.com/highlight/detail?id=2519856750","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519856750?lang=en_us&edition=fundamental","pubTime":"2025-03-13 23:47","pubTimestamp":1741880850,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Metropolitan Bank, Fossil, MeiraGTxEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nL4N3PW19Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRX11.SGD","PCAR","BK4570","LU0276348264.USD","LU2250418816.HKD","MGTX","KYMR","TRIB","ATEN","AEO","TARS","ALKT","LU0162691827.USD","LU2506952170.USD","LU0238689110.USD","SPIR","LU1043141123.HKD","ETNB","KNSA","BBW","AVAH","FOSL","LU1496350171.SGD","NN","LU2430703178.SGD","GIII","LU0096364046.USD","NVAX","DLTR","LU2317271919.USD","MNTK","IE00BMPRXQ63.HKD","LU2498475776.HKD","APGE","LU2065169927.USD","AEYE","NOVA","LYV","MCB","NEM"],"gpt_icon":1},{"id":"2519683069","title":"BUZZ-Citi initiates Apogee with \"buy\" rating on potential for eczema drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2519683069","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519683069?lang=en_us&edition=fundamental","pubTime":"2025-03-13 22:17","pubTimestamp":1741875471,"startTime":"0","endTime":"0","summary":"BUZZ-Citi initiates Apogee with \"buy\" rating on potential for eczema drug** Brokerage Citi starts coverage on Apogee Therapeutics APGE.O with \"buy\" rating** Brokerage sets PT at $95, representing more than double upside to the stock's last close** Brokerage sees peak combined adjusted revenues of $2.2 billion from co's experimental drug candidate APG777 to treat atopic dermatitis  or often called as eczema, a type of skin disease, and asthma     ** Citi says \"capturing a fraction of the Dupixent patient in AD is itself a multi-billion dollar opportunity\"** Dupixent is jointly developed by Sanofi SASY.PA and Regeneron REGN.O for patients with AD and asthma** Brokerage believes physicians are unlikely to switch well-managed patients from Dupixent to APG777 unless the latter shows comparable or superior efficacy with similar safety profile ** All eight brokerages covering the stock rate it at \"buy\" or higher, their median PT is $93.5** APGE has fallen 44.4% in the past 12 months  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nL4N3PW11O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","APGE"],"gpt_icon":0},{"id":"2519288030","title":"Citigroup Initiates Apogee Therapeutics at Buy With $95 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2519288030","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519288030?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:13","pubTimestamp":1741864400,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics (APGE) has an average rating of buy and mean price target of $93.71, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APGE"],"gpt_icon":0},{"id":"2519878538","title":"BUZZ-Citi starts coverage on 'insulated' SMid biotechs amid healthcare policy uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=2519878538","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519878538?lang=en_us&edition=fundamental","pubTime":"2025-03-13 18:56","pubTimestamp":1741863404,"startTime":"0","endTime":"0","summary":"BUZZ-Citi starts coverage on 'insulated' SMid biotechs amid healthcare policy uncertainty   ** Brokerage Citi initiates coverage on eight small and mid-cap  biotechs - 89bio ETNB.O, Apogee Therapeutics APGE.O, Avidity Biosciences RNA.O, BioNTech 22UAy.DE, Kiniksa Pharmaceuticals KNSA.O, Kymera Therapeutics KYMR.O, Moderna MRNA.O and PTC Therapeutics PTCT.O** Citi suggests SMid biotechs could be a good alternative to larger-cap stocks amid healthcare policy uncertainty** Recent economic uncertainties, including increased tariffs and slowing economic growth, have \"underscored the defensive attributes\" of biotech and pharma stocks, brokerage says ** Higher-growth large caps such as Eli Lilly LLY.N and Vertex Pharma VRTX.O are likely able to absorb potential policy headwinds and \"catalyst-driven\" SMid biotechs are \"insulated from macro uncertainties\" - Citi** YTD, S&P500 Health Care index .SPXHC has grown ~5%, NYSE Arca Pharmaceutical Index .DRG has gained ~6% and NASDAQ Biotechnology Inde","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nL4N3PW0SW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJLML261.HKD","LU0820561909.HKD","LU0109391861.USD","LU1868836591.USD","MRNA","LU1551013342.USD","BK4139","LU2237443465.HKD","LU2237443978.SGD","SG9999018865.SGD","ETNB","LU0320765059.SGD","LU1291159041.SGD","LU0417517546.SGD","SGXZ81514606.USD","RNA","LU0238689110.USD","LU1868837136.USD","IE00B894F039.SGD","LU0106261372.USD","KNSA","IE00B19Z3B42.SGD","BK4007","LU1093756325.SGD","LU1917777945.USD","LU0061475181.USD","LU2023250504.SGD","LU2089984988.USD","IE0002141913.USD","LU2063271972.USD","LU1868837300.USD","LU2362541513.USD","IE00BFTCPJ56.SGD","LU2211815571.USD","BK4533","SG9999014898.SGD","PTCT","SG9999017495.SGD","LU1720051017.SGD","LU0097036916.USD","KYMR","LU0096364046.USD","APGE","LU1280957306.USD","LU0006306889.USD","LU1989771016.USD","LU2265009873.SGD","LU1064131342.USD","VRTX"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":55,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"APGE","fiscalQuarterEnding":"2025/03","expectedEps":-1.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.95},{"market":"US","date":"2025-03-03","symbol":"APGE","fiscalQuarterEnding":"2024/12","expectedEps":-0.94,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740978000000,"reportTimeType":"pre","actualEps":-1.19},{"market":"US","date":"2024-11-12","symbol":"APGE","fiscalQuarterEnding":"2024/09","expectedEps":-0.73,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.7778,"buy":0.2222,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.7778,"analysts":9,"updateTime":1741924800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APGE","date":"2025-06-06","current":-10.699527,"percent":0.951435,"low":-42.099968,"twenty":-26.74614,"median":-20.193343,"eighty":-12.998374,"high":-9.181289,"avg":-20.957073,"sd":7.856766,"marketCap":2197586600},"quantilePoints":[{"date":"2023-07-14","current":-14.120082,"twenty":-14.120082,"median":-14.120082,"eighty":-14.120082,"marketCap":728904256},{"date":"2023-07-21","current":-18.011929,"twenty":-18.356106,"median":-18.157543,"eighty":-18.011929,"marketCap":929808491},{"date":"2023-07-28","current":-20.899222,"twenty":-20.280785,"median":-18.735584,"eighty":-18.04723,"marketCap":1078855761},{"date":"2023-08-04","current":-20.732342,"twenty":-20.732342,"median":-20.114656,"eighty":-18.267856,"marketCap":1070241131},{"date":"2023-08-11","current":-21.547107,"twenty":-20.865853,"median":-20.262175,"eighty":-18.356106,"marketCap":1112300797},{"date":"2023-08-18","current":-23.166822,"twenty":-21.272247,"median":-20.482022,"eighty":-18.735584,"marketCap":1195913385},{"date":"2023-08-25","current":-24.246631,"twenty":-22.764347,"median":-20.836643,"eighty":-19.947026,"marketCap":1251655111},{"date":"2023-09-01","current":-16.923199,"twenty":-22.901778,"median":-20.784492,"eighty":-18.356106,"marketCap":1162468350},{"date":"2023-09-08","current":-17.424846,"twenty":-22.791833,"median":-20.482022,"eighty":-18.04017,"marketCap":1196926871},{"date":"2023-09-15","current":-15.33711,"twenty":-22.261745,"median":-20.262175,"eighty":-17.454355,"marketCap":1053518613},{"date":"2023-09-22","current":-15.742854,"twenty":-21.87694,"median":-20.07464,"eighty":-16.946806,"marketCap":1081389476},{"date":"2023-09-29","current":-15.255962,"twenty":-21.600116,"median":-18.735584,"eighty":-16.181057,"marketCap":1047944441},{"date":"2023-10-06","current":-15.816626,"twenty":-21.327219,"median":-18.248406,"eighty":-15.736952,"marketCap":1086456906},{"date":"2023-10-13","current":-14.754315,"twenty":-21.232981,"median":-18.011929,"eighty":-15.43744,"marketCap":1013485920},{"date":"2023-10-20","current":-14.732183,"twenty":-21.097514,"median":-17.509684,"eighty":-15.343012,"marketCap":1011965691},{"date":"2023-10-27","current":-11.065736,"twenty":-21.032725,"median":-17.443289,"eighty":-15.295798,"marketCap":760114440},{"date":"2023-11-03","current":-13.714136,"twenty":-20.892548,"median":-17.107628,"eighty":-15.064155,"marketCap":942035162},{"date":"2023-11-10","current":-11.751812,"twenty":-20.860011,"median":-16.901067,"eighty":-14.764643,"marketCap":807241535},{"date":"2023-11-17","current":-12.191046,"twenty":-20.815783,"median":-16.340404,"eighty":-14.242502,"marketCap":851834915},{"date":"2023-11-24","current":-12.473884,"twenty":-20.732342,"median":-15.9863,"eighty":-13.271633,"marketCap":871597891},{"date":"2023-12-01","current":-14.149156,"twenty":-20.643994,"median":-15.77974,"eighty":-12.959786,"marketCap":988655514},{"date":"2023-12-08","current":-15.76641,"twenty":-20.320051,"median":-15.713345,"eighty":-13.06857,"marketCap":1101659195},{"date":"2023-12-15","current":-16.854248,"twenty":-20.280785,"median":-15.705968,"eighty":-13.227243,"marketCap":1177670639},{"date":"2023-12-22","current":-18.52952,"twenty":-20.262175,"median":-15.76641,"eighty":-13.271633,"marketCap":1294728262},{"date":"2023-12-29","current":-21.77128,"twenty":-20.316166,"median":-15.824003,"eighty":-13.537135,"marketCap":1521242365},{"date":"2024-01-05","current":-20.48763,"twenty":-20.454114,"median":-15.9863,"eighty":-13.786432,"marketCap":1431548862},{"date":"2024-01-12","current":-23.098443,"twenty":-20.721111,"median":-16.285075,"eighty":-14.084509,"marketCap":1613976327},{"date":"2024-01-19","current":-23.34502,"twenty":-20.899222,"median":-16.57141,"eighty":-14.120082,"marketCap":1631205588},{"date":"2024-01-26","current":-26.1734,"twenty":-21.423171,"median":-16.854248,"eighty":-14.149156,"marketCap":1828835342},{"date":"2024-02-02","current":-24.650426,"twenty":-22.136094,"median":-16.901067,"eighty":-14.410237,"marketCap":1722419321},{"date":"2024-02-09","current":-26.833356,"twenty":-22.901778,"median":-17.107628,"eighty":-14.722084,"marketCap":1874948952},{"date":"2024-02-16","current":-25.919571,"twenty":-23.170966,"median":-17.443289,"eighty":-14.732183,"marketCap":1811099339},{"date":"2024-02-23","current":-25.462679,"twenty":-23.458155,"median":-17.594521,"eighty":-14.738085,"marketCap":1779174532},{"date":"2024-03-01","current":-25.252364,"twenty":-23.903055,"median":-18.011929,"eighty":-14.745463,"marketCap":1764478986},{"date":"2024-03-08","current":-39.349598,"twenty":-24.476372,"median":-18.248406,"eighty":-14.75284,"marketCap":3304775976},{"date":"2024-03-15","current":-39.31944,"twenty":-25.034796,"median":-18.52952,"eighty":-14.795627,"marketCap":3302243192},{"date":"2024-03-22","current":-40.133695,"twenty":-25.237859,"median":-19.967125,"eighty":-14.977105,"marketCap":3370628348},{"date":"2024-03-28","current":-41.080642,"twenty":-25.310382,"median":-20.039026,"eighty":-15.024319,"marketCap":3450157751},{"date":"2024-04-05","current":-35.585933,"twenty":-25.583066,"median":-20.203754,"eighty":-15.040549,"marketCap":2988684589},{"date":"2024-04-12","current":-40.39061,"twenty":-25.977589,"median":-20.297181,"eighty":-15.087984,"marketCap":3392205375},{"date":"2024-04-19","current":-33.647243,"twenty":-26.134238,"median":-20.48763,"eighty":-15.119386,"marketCap":2825863713},{"date":"2024-04-26","current":-30.802638,"twenty":-26.87687,"median":-20.704265,"eighty":-15.154157,"marketCap":2586959527},{"date":"2024-05-03","current":-35.061005,"twenty":-31.417884,"median":-20.865853,"eighty":-15.223502,"marketCap":2944598502},{"date":"2024-05-10","current":-35.544605,"twenty":-33.702281,"median":-21.144633,"eighty":-15.273667,"marketCap":2985213654},{"date":"2024-05-17","current":-30.341768,"twenty":-33.2059,"median":-21.423171,"eighty":-15.316454,"marketCap":3142011451},{"date":"2024-05-24","current":-25.989488,"twenty":-32.751748,"median":-21.791716,"eighty":-15.341537,"marketCap":2691315483},{"date":"2024-05-31","current":-26.170128,"twenty":-32.249341,"median":-22.218395,"eighty":-15.347905,"marketCap":2710021411},{"date":"2024-06-07","current":-23.773834,"twenty":-31.497141,"median":-22.764347,"eighty":-15.361417,"marketCap":2461875577},{"date":"2024-06-14","current":-24.341154,"twenty":-31.168024,"median":-22.917136,"eighty":-15.378422,"marketCap":2520623884},{"date":"2024-06-21","current":-21.479149,"twenty":-30.802638,"median":-22.901778,"eighty":-15.396128,"marketCap":2224251827},{"date":"2024-06-28","current":-22.551696,"twenty":-30.67474,"median":-22.901778,"eighty":-15.416784,"marketCap":2335318278},{"date":"2024-07-05","current":-21.168675,"twenty":-30.454668,"median":-22.551696,"eighty":-15.452028,"marketCap":2192101012},{"date":"2024-07-12","current":-25.927394,"twenty":-30.290963,"median":-22.599678,"eighty":-15.490824,"marketCap":2684885320},{"date":"2024-07-15","current":-27.107194,"twenty":-30.240158,"median":-22.64766,"eighty":-15.512581,"marketCap":2807058416},{"date":"2024-08-02","current":-25.825784,"twenty":-30.189354,"median":-22.706004,"eighty":-15.534337,"marketCap":2674363235},{"date":"2024-08-09","current":-22.78314,"twenty":-29.894686,"median":-22.901778,"eighty":-15.586554,"marketCap":2359285249},{"date":"2024-08-16","current":-22.360657,"twenty":-29.660984,"median":-22.773744,"eighty":-15.598555,"marketCap":2649402436},{"date":"2024-08-23","current":-23.604561,"twenty":-29.231009,"median":-22.862169,"eighty":-15.66023,"marketCap":2796786413},{"date":"2024-08-30","current":-24.399278,"twenty":-28.636347,"median":-22.994085,"eighty":-15.707443,"marketCap":2890948398},{"date":"2024-09-06","current":-23.811878,"twenty":-28.151516,"median":-23.098851,"eighty":-15.725149,"marketCap":2821350409},{"date":"2024-09-13","current":-24.28081,"twenty":-27.512504,"median":-23.170966,"eighty":-15.752276,"marketCap":2876911828},{"date":"2024-09-20","current":-26.136794,"twenty":-27.110581,"median":-23.268758,"eighty":-15.786496,"marketCap":3096818079},{"date":"2024-09-27","current":-28.649283,"twenty":-28.484417,"median":-23.34502,"eighty":-15.822528,"marketCap":3394510318},{"date":"2024-10-04","current":-28.061884,"twenty":-28.569318,"median":-23.434542,"eighty":-15.893348,"marketCap":3324912329},{"date":"2024-10-11","current":-26.610663,"twenty":-28.484417,"median":-23.533922,"eighty":-16.011479,"marketCap":3152964356},{"date":"2024-10-18","current":-27.755844,"twenty":-28.448831,"median":-23.612583,"eighty":-16.121447,"marketCap":3288651192},{"date":"2024-10-25","current":-25.643182,"twenty":-28.355515,"median":-23.773834,"eighty":-16.274009,"marketCap":3038332374},{"date":"2024-10-31","current":-27.099339,"twenty":-28.252419,"median":-23.811878,"eighty":-16.385155,"marketCap":3210865204},{"date":"2024-11-08","current":-28.654219,"twenty":-28.465143,"median":-23.860074,"eighty":-16.567059,"marketCap":3395095175},{"date":"2024-11-15","current":-19.789128,"twenty":-28.485404,"median":-23.853973,"eighty":-16.630879,"marketCap":2902332924},{"date":"2024-11-22","current":-16.628998,"twenty":-28.465143,"median":-23.803477,"eighty":-16.671147,"marketCap":2438858722},{"date":"2024-11-29","current":-17.517481,"twenty":-28.399895,"median":-23.76973,"eighty":-16.839744,"marketCap":2569166386},{"date":"2024-12-06","current":-18.297329,"twenty":-28.288946,"median":-23.604561,"eighty":-16.854248,"marketCap":2683541235},{"date":"2024-12-13","current":-17.195455,"twenty":-28.106309,"median":-23.497667,"eighty":-16.861788,"marketCap":2521936971},{"date":"2024-12-20","current":-18.243012,"twenty":-28.061884,"median":-23.417542,"eighty":-16.878936,"marketCap":2675574828},{"date":"2024-12-27","current":-18.305089,"twenty":-28.042139,"median":-23.34502,"eighty":-16.878936,"marketCap":2684679293},{"date":"2025-01-03","current":-18.29345,"twenty":-27.898004,"median":-23.314068,"eighty":-16.905494,"marketCap":2682972206},{"date":"2025-01-10","current":-19.092697,"twenty":-27.799282,"median":-23.175118,"eighty":-16.935003,"marketCap":2800192201},{"date":"2025-01-17","current":-14.239016,"twenty":-27.785817,"median":-23.13304,"eighty":-16.857264,"marketCap":2088336797},{"date":"2025-01-24","current":-15.60084,"twenty":-27.774326,"median":-23.084739,"eighty":-16.58873,"marketCap":2288066011},{"date":"2025-01-31","current":-16.489324,"twenty":-27.755844,"median":-22.901778,"eighty":-16.251878,"marketCap":2418373675},{"date":"2025-02-07","current":-16.155657,"twenty":-27.743997,"median":-22.822654,"eighty":-16.03771,"marketCap":2369437172},{"date":"2025-02-14","current":-14.068303,"twenty":-27.666994,"median":-22.64766,"eighty":-15.83959,"marketCap":2063299516},{"date":"2025-02-21","current":-13.17206,"twenty":-27.548527,"median":-22.532767,"eighty":-15.742854,"marketCap":1931853794},{"date":"2025-02-28","current":-11.845154,"twenty":-27.262231,"median":-22.345048,"eighty":-15.697836,"marketCap":1737245842},{"date":"2025-03-07","current":-11.30201,"twenty":-27.112839,"median":-22.212997,"eighty":-15.60472,"marketCap":2058615932},{"date":"2025-03-14","current":-12.223647,"twenty":-27.107194,"median":-21.977899,"eighty":-15.577851,"marketCap":2226488393},{"date":"2025-03-21","current":-12.874214,"twenty":-27.104275,"median":-21.832491,"eighty":-15.410728,"marketCap":2344986602},{"date":"2025-03-28","current":-12.51704,"twenty":-27.099339,"median":-21.774807,"eighty":-15.344488,"marketCap":2279928762},{"date":"2025-04-04","current":-11.158503,"twenty":-27.089467,"median":-21.479149,"eighty":-15.267174,"marketCap":2032476621},{"date":"2025-04-11","current":-9.54803,"twenty":-27.02252,"median":-21.347709,"eighty":-15.123173,"marketCap":1739135468},{"date":"2025-04-17","current":-10.217731,"twenty":-27.018004,"median":-21.19592,"eighty":-15.044975,"marketCap":1861118918},{"date":"2025-04-25","current":-11.815448,"twenty":-27.009303,"median":-21.066101,"eighty":-14.75284,"marketCap":2152136576},{"date":"2025-05-02","current":-12.501095,"twenty":-26.955194,"median":-20.851248,"eighty":-14.659715,"marketCap":2277024394},{"date":"2025-05-09","current":-12.057816,"twenty":-26.905994,"median":-20.676189,"eighty":-14.171382,"marketCap":2196282968},{"date":"2025-05-16","current":-11.538128,"twenty":-26.893009,"median":-20.509211,"eighty":-14.009329,"marketCap":2369827680},{"date":"2025-05-23","current":-11.469666,"twenty":-26.845089,"median":-20.320051,"eighty":-13.400194,"marketCap":2355766140},{"date":"2025-05-30","current":-10.709474,"twenty":-26.800437,"median":-20.280785,"eighty":-13.20517,"marketCap":2199629509},{"date":"2025-06-06","current":-10.699527,"twenty":-26.74614,"median":-20.193343,"eighty":-12.998374,"marketCap":2197586600}],"updateTime":1749378120258}}}